IPO Premiums
IPO calendar
QLListed

Quest Laboratories Limited

Book Built Issue IPO · NSE

Price band
₹93 - ₹97
Lot size
1,200 shares
Issue amount
₹43.16 cr
Total subscription
85.34×
Current price₹90.2
Listing price ₹155.1
Watch live price ↗
Opens
15 May 2024
Closes
17 May 2024
Allotment
21 May 2024
Listing
23 May 2024

Offer at a glance

Issue overview

Issue size
44,49,600 shares
Face value
₹10 Per Equity Share
Minimum investment
₹1,11,600
Fresh issue
₹43.16 cr
Offer for sale
₹0 cr
Registrar
Bigshare Services Private Limited
Listing exchange
NSE
Maximum investment
₹1,16,400
Issue type
Book Built Issue IPO
Shares before issue
1,19,37,600
Shares after issue
1,63,87,200

Lot sizes

CategoryLotsSharesAmount
RETAIL11,200₹1,16,400
HNI22,400₹2,32,800

Share reservation

RETAIL33.68%
NII (HNI)14.72%
Anchor27.78%
QIB18.69%
Market Maker5.12%

Subscription & GMP

Subscription by category

Total subscribed85.34×

Missing multiples are calculated from bids and offered shares when available.

QIB57.2×
NIB184.45×
RETAIL57.63×

GMP history

0408010 Mar: ₹8014 Nov: ₹8018 Nov: ₹8026 Nov: ₹80
10 Mar₹8026 Nov

Subscription demand

Amounts in ₹ crore. HNI subcategories are included in the NII total.

CategoryOfferedDemand
QIBs8.07461.44
RETAIL14.54837.79

Financial performance

Company financials

In Lakhs · Reported periods may include interim results.

Revenue & profitIn Lakhs
02,0004,0006,0008,000Mar-21 · Revenue: 3,043.55Mar-21 · Profit after tax: 65.5Mar-21Mar-22 · Revenue: 5,954.2Mar-22 · Profit after tax: 410.5Mar-22Mar-23 · Revenue: 6,186.6Mar-23 · Profit after tax: 502.85Mar-23Dec-23 · Revenue: 6,217.83Dec-23 · Profit after tax: 774.93Dec-23
RevenueProfit after tax

Key performance indicators

MetricDec-23Mar-23Mar-22
EPS7.184.663.81
ROE34.0340.251.69
ROCE000
RONW34.0333.4741.08
PRE IPO(PE)4.5900
POST IPO(PE)23.0300

Values and labels as reported in the issue data.

Company information

Company profile

Founded in June 1998, Quest Laboratories Limited is a well-known pharmaceutical company that produces a wide range of medicines, including antibiotics, antimalarials, pain relievers, respiratory treatments, diabetes medications, and antidepressants. The company operates across 12 states and 2 union territories in India, including Uttar Pradesh, Maharashtra, Delhi, Karnataka, and more. Headquartered in Dhar, Madhya Pradesh, Quest Laboratories runs advanced manufacturing facilities that meet strict international quality standards like WHO GMP, GLP, and ISO certifications. With a skilled team of 83 professionals handling production, quality control, engineering, inventory, and administration, the company is dedicated to maintaining top-quality standards and delivering reliable medical solutions.

Strengths

  • Wide Product Range: The company offers a variety of medicines for different health needs, making it adaptable to market changes and creating more opportunities for growth.
  • Trusted by Government Institutions: Working with government institutions shows the company’s strong reputation and reliability, ensuring stable and long-term financial success.
  • Strong Product Portfolio: Covering multiple medical fields, the company stays competitive, expands its market reach, and remains a key player in the pharmaceutical industry.

Risk factors

  • Legal Challenges: Ongoing legal cases could affect the company’s business, reputation, and financial health. Negative outcomes, especially those involving the promoter, may lead to disruptions and financial risks.
  • Promoter’s Legal Issues: The promoter’s legal troubles, including imprisonment and appeals, create uncertainty about the company’s future. Any unfavorable rulings could impact operations and stability.
  • Quality Control Risks: Issues in manufacturing or product quality could harm the company’s reputation, leading to legal troubles, regulatory fines, and financial setbacks. Maintaining high standards is crucial for market trust and long-term success.

Promoters

Mr. Anil Kumar Sabarwal

Ms. Tejaswini Sabarwal

Registrar & documents

Lead manager

Shreni Shares Limited

Registered office

Plot No. 45, Sector III, Pithampur Industrial Area, Pithampur, Dhar - 454775

07292292374

[email protected]Company website ↗

Frequently Asked Questions

What is Quest Laboratories IPO GMP today?

As of today, Quest Laboratories IPO Grey Market Premium (GMP) is reported at +₹80 per share. Based on the upper price band of ₹97, the estimated listing price is ₹177 (+82.5% expected listing gain). Please note that GMP is an unofficial market estimate for sentiment tracking and does not guarantee the actual listing price.

What is the lot size and minimum investment for Quest Laboratories IPO?

The minimum bid lot size for Quest Laboratories IPO is 1,200 shares. At the cut-off price of ₹97 per share, retail investors need a minimum application amount of ₹1,16,400 per lot. Retail applicants can apply for a maximum of 1 lots (up to ₹2,00,000).

When will Quest Laboratories IPO allotment status be announced?

The allotment status for Quest Laboratories IPO is scheduled to be finalized on 21 May 2024. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through Bigshare Services Private Limited's official portal or via BSE/NSE allotment portals.

How can I check Quest Laboratories IPO allotment status online by PAN?

To check Quest Laboratories IPO allotment status: 1) Visit the registrar portal (Bigshare Services Private Limited) or the BSE IPO allotment page. 2) Select 'Quest Laboratories Limited' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.

Explore More IPO Analysis & Live Tools

Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.

Regulatory Disclaimer: Grey Market Premium (GMP) is an unofficial, unregulated indicator of market sentiment and does not represent a stock exchange transaction, guarantee, or investment advice. IPO Premiums is an informational and research portal and is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before applying for any IPO.